^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Prolymphocytic Leukemia |
| Drug: | pentostatin (Adenosine deaminase inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
T-Cell Prolymphocytic Leukemia....Second-line therapy...Preferred regimen: Pentostatin